"Valeant is the biggest standout. The Canadian company, a favorite investment of hedge fund icon Bill Ackman, has pursued a strategy of buying out other companies and drugs, slashing R&D budgets, and dramatically increasing prices. Its average price increase so far this year is 66%. Behind it are Allergan, Mallinckrodt, and Mylan."
'via Blog this'
Return Home: The Health, Drug, Prescription, and GMP Supersite Blog
SkillsPlus Intl Inc. - The best GMP training, best QSR training, best instructors
SkillsPlus Intl Info Blog
The Health, Drug, Prescription, and GMP Supersite Gift Store
No comments:
Post a Comment